| Dec'17 | Dec'16 | |||||
|---|---|---|---|---|---|---|
Operating activities | ||||||
Net earnings (loss) for the year | ||||||
9,684 | 3,910 | |||||
Items not affecting cash: | ||||||
Share-based compensation | ||||||
2,861 | 3,482 | |||||
Depreciation and depletion | ||||||
16,990 | 14,261 | |||||
Deferred income tax expense (recovery) | ||||||
-6,425 | -38 | |||||
Unrealized foreign exchange loss (gain) | ||||||
-403 | 462 | |||||
(Gain) loss on available for sale assets | ||||||
-72 | 269 | |||||
Finance costs | ||||||
715 | 1,172 | |||||
Write off of IVA receivable | ||||||
0 | 434 | |||||
Write off of mineral properties | ||||||
233 | 0 | |||||
Net changes in non-cash working capital | ||||||
7,993 | 983 | |||||
Cash from operating activities | ||||||
15,590 | 22,969 | |||||
Investing activities | ||||||
Property, plant and equipment expenditures | ||||||
39,835 | 19,635 | |||||
Proceeds from disposition of available for sale assets | ||||||
72 | 449 | |||||
Redemption of non-current deposits | ||||||
49 | 120 | |||||
Cash used in investing activities | ||||||
-39,714 | -19,066 | |||||
Financing activities | ||||||
Repayment of credit facility | ||||||
9,000 | 13,000 | |||||
Restricted cash | ||||||
-1,000 | 0 | |||||
Repayment of obligation under finance lease | ||||||
0 | 1,180 | |||||
Debt issuance costs | ||||||
0 | 474 | |||||
Interest paid | ||||||
461 | 779 | |||||
Public equity offerings | ||||||
0 | 55,353 | |||||
Exercise of options | ||||||
142 | 10,548 | |||||
Share issuance costs | ||||||
0 | 2,005 | |||||
Cash used in financing activites | ||||||
-10,319 | 48,463 | |||||
Effect of exchange rate change on cash and cash equivalents | ||||||
403 | -462 | |||||
Increase (decrease) in cash and cash equivalents | ||||||
-34,443 | 52,366 | |||||